Sugi Predict

Sugi Predict / Compounds / SCHEMBL3172173

SCHEMBL3172173

SCHEMBL3172173

CCCCCC(=O)Oc1ccc(C=O)cc1

nearest known ligand 0.84

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 5/20 0.84
▸ SMN1; SMN2 Q16637 2/20 0.55
▸ RET P07949 1/20 0.49
▸ ALDH1A1 P00352 2/20 0.47
▸ LMNA P02545 2/20 0.47
▸ MAPT P10636 2/20 0.47
▸ HTT P42858 1/20 0.47
▸ HSD17B10 Q99714 1/20 0.47
▸ EGFR P00533 2/20 0.47
▸ ERBB2 P04626 2/20 0.47
▸ NPC1 O15118 1/20 0.46
▸ RAB9A P51151 1/20 0.46
▸ TOP2A P11388 2/20 0.46
▸ HPGD P15428 2/20 0.46
▸ BCL9 O00512 1/20 0.45
▸ CTNNB1 P35222 1/20 0.45
▸ THRB P10828 1/20 0.44
▸ POLM Q9NP87 1/20 0.44
▸ POLK Q9UBT6 1/20 0.44
▸ POLL Q9UGP5 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9746611 0.98 KMT2A (0.81) KMT2ASMN1; SMN2RETALDH1A1LMNA
SCHEMBL1665845 0.98 KMT2A (0.81) KMT2ASMN1; SMN2RETALDH1A1LMNA
SCHEMBL13263852 0.98 KMT2A (0.81) KMT2ASMN1; SMN2RETALDH1A1LMNA
SCHEMBL28437309 0.98 KMT2A (0.81) KMT2ASMN1; SMN2RETALDH1A1LMNA
SCHEMBL7285233 0.95 KMT2A (0.81) KMT2ASMN1; SMN2RETALDH1A1LMNA
SCHEMBL14575820 0.92 KMT2A (1.00) KMT2ASMN1; SMN2ALDH1A1LMNAMAPT
SCHEMBL5386778 0.92 KMT2A (0.70) KMT2ASMN1; SMN2RETALDH1A1LMNA
SCHEMBL1665645 0.88 KMT2A (0.74) KMT2ASMN1; SMN2ALDH1A1LMNAMAPT
SCHEMBL14575315 0.88 KMT2A (0.93) KMT2ASMN1; SMN2ALDH1A1LMNAMAPT
SCHEMBL15430731 0.88 KMT2A (0.65) KMT2ASMN1; SMN2RETALDH1A1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108047105-B 3-/4-ester-group-substituted benzaldehyde thiosemicarbazone derivative and preparation and application thereof 广东轻工职业技术学院 2020-06-26 — — CN disclosed
US-7718277-B2 Electronic devices comprising organic iridium compositions GENERAL ELECTRIC COMPANY (US) 2010-05-18 — — US disclosed
US-7718087-B2 Organic iridium compositions and their use in electronic devices GENERAL ELECTRIC COMPANY (US) 2010-05-18 — — US disclosed
US-7704610-B2 organic light emitting device comprising deuterated organic iridium complex; optoelectronic devices, photovoltaic devices; enhanced color properties and light output efficiencies GENERAL ELECTRIC COMPANY (US) 2010-04-27 — — US disclosed
US-20100090586-A1 ELECTRONIC DEVICES COMPRISING ORGANIC IRIDIUM COMPOSITIONS GENERAL ELECTRIC COMPANY 2010-04-15 — — US disclosed
US-7695640-B2 Organic iridium compositions and their use in electronic devices GENERAL ELECTRIC COMPANY (US) 2010-04-13 — — US disclosed
US-7691292-B2 organic light emitters; photovoltaic cells; electrophosphorescent GENERAL ELECTRIC COMPANY (US) 2010-04-06 — — US disclosed
US-7691494-B2 Electronic devices comprising organic iridium compositions GENERAL ELECTRIC COMPANY (US) 2010-04-06 — — US disclosed
US-20100051869-A1 ORGANIC IRIDIUM COMPOSITIONS AND THEIR USE IN ELECTRONIC DEVICES GENERAL ELECTRIC COMPANY 2010-03-04 — — US disclosed
US-7652151-B2 Ketopyrroles useful as ligands in organic iridium compositions GENERAL ELECTRIC COMPANY (US) 2010-01-26 — — US disclosed
US-7608677-B2 Method for preparing polymeric organic iridium compositions GENERAL ELECTRIC COMPANY (US) 2009-10-27 — — US disclosed
US-20080023672-A1 Organic iridium compositions and their use in electronic devices GENERAL ELECTRIC COMPANY 2008-01-31 — — US disclosed
US-20080026249-A1 Electronic devices comprising organic iridium compositions GENERAL ELECTRIC COMPANY 2008-01-31 — — US disclosed
US-20080026250-A1 Electronic devices comprising organic iridium compositions GENERAL ELECTRIC COMPANY 2008-01-31 — — US disclosed
US-20080023671-A1 Organic iridium compositions and their use in electronic devices GENERAL ELECTRIC COMPANY 2008-01-31 — — US disclosed
US-20080027028-A1 Ketopyrroles useful as ligands in organic iridium compositions GENERAL ELECTRIC COMPANY 2008-01-31 — — US disclosed
US-20080026477-A1 Method for preparing polymeric organic iridium compositions GENERAL ELECTRIC COMPANY (US) 2008-01-31 — — US disclosed
US-4614723-A Porphyrin derivatives as fluorescent markers for immunoassays HOFFMANN-LA ROCHE INC. (US) 1986-09-30 — — US disclosed
US-4415572-A CARDIOTONIC AND INOTROPIC AGENTS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1983-11-15 — — US disclosed
US-4254035-A BY REACTING GLYCINE AND AN AROMATIC ALDEHYDE IN THE PRESENCE OF ACETIC ANHYDRIDE DEUTSCHE GOLD- UND SILBER-SCHEIDEANSTALT VORMALS ROESSLER (DE) 1981-03-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080027028-A1 Ketopyrroles useful as ligands in organic iridium compositions OR10J3, OPRD1, OCIAD1 KMT2A 2512/4885SMN1; SMN2 4698/4885RET 3632/4885
US-20100051869-A1 ORGANIC IRIDIUM COMPOSITIONS AND THEIR USE IN ELECTRONIC DEVICES OCIAD1, OCIAD2, OXER1 KMT2A 3401/4885SMN1; SMN2 4277/4885RET 3746/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.